top of page
New Drugs by Design

Computational Biology Platform that's Yielded a Pipeline of Experimentally-Validated New Drugs
Discovered new fundamental biology
We own [by granted patents]
invented preclinical
and repurposed clinical stage drugs
Our mission is new drugs for cancer,
the diseases of aging (e.g., Alzheimer's disease),
and AGING itself (which has cosmetic applications)


Dr. Michael Forrest
Founder CEO
Cambridge University biochemistry graduate.
Ph.D. computer science.

Professor George Church
Advisor
Harvard Medical School

Professor Bruno Conti
Advisor
Scripps Research Institute

Professor Varinder Aggarwal
Advisor
Bristol University chemistry department. Robert Robinson lecturer at Oxford University.
bottom of page